GlassScriptPhysician profile
Umang Khetarpal
NPI 1306847215
$1,490.04
in general payments reported to CMS, 2019-2025
12 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2021: $285 · 2022: $402 · 2023: $72.66 · 2024: $74.10 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $326.26 | 2021-2025 | Xpress Loprofile |
| Optinose US, INC. | $276.68 | 2021-2025 | |
| Acclarent, INC | $238.81 | 2019 | |
| Genzyme Corporation | $196.18 | 2021-2025 | |
| Integra Lifesciences Corporation | $132.07 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| E.R. Squibb & Sons, L.L.C. | $118.97 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $47.37 | 2022 | |
| Medtronic, INC. | $40.07 | 2022 | |
| Boston Scientific Corporation | $35.93 | 2023 | Watchman Flx |
| Glaxosmithkline, LLC. | $34.17 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $24.82 | 2025 | Neffy |
| Medtronic USA, INC. | $18.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umang Khetarpal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.